Activation of CD4+ T cells is a crucial step in the elimination of Histoplasma capsulatum yeast cells from tissues. However, only a limited amount of information exists concerning the immunobiology of H. capsulatum-reactive T cells that are CD4+. To facilitate the analysis of the functional activities of this T-cell subpopulation, we developed a panel of 10 murine T-cell hybridomas from splenocytes of immune C57BL/6 mice. All hybridomas reacted with monoclonal anti-CD4+ antibody and released interleukin-2 after stimulation with histoplasmin. Within 3 weeks, the reactivity of hybridomas to histoplasmin declined dramatically, yet the cells responded vigorously to yeast-phase preparations that were enriched for cytosol, cell wall, or cell membrane. Of 10 hybridomas studied, only one recognized heterologous fungal antigens. Responsiveness to yeast-phase antigens was restricted by I-Ab. We mapped determinants in cytosol and cell wall or cell membrane by the technique of one-dimensional T-cell immunoblotting. The patterns of responses of hybridomas to cytosol were nearly uniform. All hybridomas responded to two immunodominant regions in cytosol with masses ranging from l18 to 26 kilodaltons (kDa) and 35 to 39 kDa. All hybridomas tested responded to determinants in the cell wall or cell membrane preparation with masses of 35 to 39 kDa. These hybridomas provide a useful tool for defining yeast-phase antigens that trigger T-cell activation.
Histoplasma capsulatum is a dimorphic fungal pathogen that produces a broad spectrum of disease. Most often, infection resolves without therapeutic intervention. The capacity of host defenses to limit the replication of this intracellular pathogen is chiefly dependent on a collaborative interaction between antigen-reactive T cells and macrophages (6, 7, 9, 14, 16 ). The precise sequence of events that results in growth restriction has not been defined. Accumulating evidence suggests that CD4+ T cells, upon recognition of H. capsulatum antigens bound to class II major histocompatibility complex molecules, release lymphokines that activate the antifungal activity of macrophages (9, 18, 20) . One of the principle lymphokines involved in arming murine macrophages is gamma interferon (19) .
Although it is clear that T lymphocytes and, in particular, CD4+ T cells play a central role in the elimination of H. capsulatum yeast cells (6, 7, 9) , information about the biological properties of H. capsulatum-reactive CD4+ T cells is incomplete. To gain a better understanding of the function of this T-cell subpopulation, we generated a panel of 10 T-cell hybridomas that respond to H. capsulatum antigens from splenocytes of C57BL/6 mice immunized with viable organisms. The data demonstrate that the T-cell hybridomas release interleukin-2 (IL-2) after stimulation with histoplasmin (HKC) or yeast-phase antigens. Only 1 of 10 hybridomas responds to heterologous fungal antigens. In addition, the recognition of yeast-phase antigens is restricted by I-A'. T-cell immunoblotting was used to identify epitopes in yeast-phase antigens that stimulate T-cell hybridomas.
MATERIALS AND METHODS Mice. Male C57BL/6, B10.A(4R), B10.A(5R), and B10.MBR mice were purchased from Jackson Laboratory, Bar Harbor, Maine.
Antigens. HKC was prepared as described previously (10) .
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The protein content was 120 ,ug/ml. Yeast-phase preparations were isolated in the following manner. Strain G217B yeast cells were inoculated into Ham F-12 medium supplemented with cystine (8.4 ,ug/liter), N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (6 g/liter), glutamic acid ( results shown in Table 1 . Following this observation, cryopreserved hybridomas were retrieved and tested for reactivity to HKC as well as the yeast-phase preparations. The hybridomas retained vigorous responsiveness to the yeastphase preparations, but reactivity to HKC either remained diminished or was nonexistent. For example, 2C4, which had been recovered from freezing, proliferated vigorously against Cyto (21,126 ± 699 cpm) but only weakly against HKC (2,656 ± 161 cpm; unstimulated cells, 242 ± 54 cpm). The yeast-phase preparations, therefore, contained determinants recognized by T cells. Moreover, there was an irreversible decrement or loss of reactivity to HKC.
Responses of hybridomas to heterologous fungal antigens. T-cell hybridomas were incubated with a battery of heterologous fungal antigens or Cyto, and IL-2 production was measured. Only one hybridoma, lAl, responded to heterologous fungal antigens (Table 3) . It reacted vigorously to C-ASWS and very weakly to B-ASWS. None of the hybridomas recognized cryptococcal antigen. With the exception of lAl, the hybridomas demonstrated specificity for H. capsulatum antigens.
Major histocompatibility complex restriction of antigen presentation. T-cell hybridomas were cultured with irradiated splenocytes from C57BL/6 mice and from congenic B10.MBR, B1O.A(4R), and B10.A(5R) mice in the presence or absence of Cyto. Data for 5 of 10 hybridomas are shown (Fig. 1) . Numerous silver-staining bands ranging from <14 to 200 kDa also were apparent in CW/M (A. Gomez, J. Rhodes, and G. Deepe, submitted for publication). Western blot (immunoblot) analysis did not demonstrate M or H antigens in Cyto or CW/M (data not shown).
T-cell immunoblotting analyses of Cyto and CW/M. Cyto and CW/M were separated by one-dimensional SDS-PAGE and transferred to NC, and fractions of NC-bound proteins were assayed for reactivity. All hybridomas recognized determinants in Cyto with masses ranging between <18 and 39 kDa. Results for 6 of 10 hybridomas are shown in Fig. 2 separated by electrophoresis is illustrated in Fig. 3 . Fractions that are not stimulatory do not contain inhibitors of IL-2 activity. We explored the possibility that the nonantigenic fractions stimulated the release of molecules that inhibited IL-2 activity or were toxic for CTLL-2 cells. Hybridoma 2C4 was incubated with 50 ,ul of fractions with masses of >39 kDa from NC-bound Cyto or fractions with masses of <35 and >39 kDa from NC-bound CW/M; 100 ,ul of supernatant was removed from each well 24 h later. CTLL-2 cells were cocultured with a suboptimal dilution (1:64) or IL-2 prepared from concanavalin A-stimulated rat splenocytes and test supernatants. The proliferative activity of CTLL-2 cells against a 1:64 dilution of IL-2 (18,040 ± 831 cpm) was considerably greater than that of cells cultured in medium (360 ± 60 cpm). The response of CTLL-2 cells to the admixture of IL-2 and supernatants from nonstimulatory fractions (range, 14,709 ± 1,659 to 21,977 ± 133 cpm) was similar to that of cells to IL-2 alone. The results indicate that supernatants from 2C4 that had been incubated with nonantigenic fractions did not contain inhibitors of IL-2 activity or molecules toxic for CTLL-2 cells. DISCUSSION In the field of mycology, others have reported the isolation of T-cell hybridomas from mice injected with cryptococcal antigen. These cells have been used as a source of factors that either suppress delayed-type hypersensitivity responses of immune mice to a cryptococcal filtrate (8) or inhibit phagocytosis by a subpopulation of murine macrophages (3). In the present investigation, the technique of immortalizing T cells by fusion with the thymoma line BW5147 was used for a different purpose. The objective was to produce a panel of CD4+ T-cell hybridomas to identify antigens reactive with H. capsulatum-specific T cells. Thus, the findings described here represent one of very few reports of T-cell hybridomas in medical mycology and extend the range of usefulness of these cells.
For the past few years, this laboratory has analyzed the immunological properties of H. capsulatum-reactive T-cell clones generated from spleens of immune C57BL/6 mice (6, 7, 9 experiments designed to examine antigenic reactivity can be performed more frequently with these cells than with T-cell clones. The reason is that after stimulation with antigen, T-cell clones usually require at least 7 days before they respond optimally to antigen again (15) . By contrast, samples of hybridomas can be removed daily and tested for antigenic reactivity. We also have observed that the recovery of cryopreserved hybrids is much more successful than is that of T-cell clones. The disadvantages of hybridomas are that they cannot be used to study cytokine regulation of T-cell growth, nor can they be used in vivo as viable cells.
When the results of the current study are compared with results obtained with CD4+ T-cell clones, several points emerge. Both types of antigen-reactive T cells were gener- Much attention has focused on identifying and purifying antigens from pathogenic microbes. The technique of T-cell immunoblotting has simplified the detection of T-cell determinants from a complex mixture of antigens prepared from microbes (2, 12) . The profiles of responses of individual hybridomas to electrophoretically separated Cyto or CW/M were fairly uniform. All hybridomas recognized two immunodominant regions in Cyto with masses of <18 to 26 kDa and of 35 to 39 kDa. Hybridomas responded to a single fraction in CW/M with a mass of 35 to 39 kDa.
CW/M and Cyto appeared to contain a common antigenic region. Since CW/M is not prepared in such a manner as to contain only membrane particles, it is possible that this molecule or molecules of 35 to 39 kDa are present only in Cyto and that they are copurified with CW/M. Alternatively, the determinants may exist separately in both fractions of H. capsulatum. The finding that antigens in Cyto and CW/M have similar masses does not imply that the amino acid sequences of the determinants are homologous. Additional studies will be required to determine if the antigenic molecules of 35 to 39 kDa in Cyto and CW/M share identity at the amino acid level.
The profile of responses of hybridomas to CW/M differs markedly from that observed with T-cell clones (Gomez et al., submitted). Five of six clones and a T-cell line respond to two immunodominant domains in CW/M with masses of 53 to 82 kDa. The difference in the pattern of responses between hybridomas and clones to CW/M indicates that there are numerous T-cell epitopes in this preparation from strain G217B yeast cells. Taken together, the heterogeneity of the responsiveness of T cells to CW/M raises concerns about which of the many determinants produce a protective response. In this regard, construction of a vaccine or an immunotherapeutic agent for histoplasmosis may remain elusive until protective epitopes can be distinguished from antigens that simply engage the T-cell receptor and do not confer protection.
